DiaMedica Therapeutics Ownership | Who Owns DiaMedica Therapeutics?


OverviewForecastFinancialsChartTranscripts

DiaMedica Therapeutics Ownership Summary


DiaMedica Therapeutics is owned by 23.37% institutional investors, 27.83% insiders, and 48.81% retail investors. Cooperman leon g is the largest institutional shareholder, holding 6.41% of DMAC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.74% of its assets in DiaMedica Therapeutics shares.

DMAC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockDiaMedica Therapeutics23.37%27.83%48.81%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Cooperman leon g3.45M6.41%$24.29M
Blackrock funding, inc. /de2.25M4.19%$15.86M
Paragon associates & paragon associates ii joint venture875.00K1.86%$5.92M
Geode capital management894.12K1.66%$6.30M
Millennium management845.31K1.57%$5.95M
Vanguard group723.12K1.46%$5.76M
State street646.74K1.20%$4.55M
Bleichroeder lp382.32K0.71%$2.69M
Vanguard capital management355.52K0.66%$2.50M
Advisor group338.11K0.63%$2.38M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Paragon associates & paragon associates ii joint venture875.00K8.05%$5.92M
Cooperman leon g3.45M0.68%$24.29M
Bleichroeder lp382.32K0.48%$2.69M
Cobalt capital management90.00K0.45%$633.60K
Members wealth101.38K0.39%$713.73K
Corient ia35.00K0.23%$246.40K
Magnolia capital advisors77.41K0.09%$544.93K
Diametric capital, lp76.62K0.06%$539.41K
Gsa capital partners llp72.56K0.03%$511.00K
Private capital management50.00K0.03%$352.00K

Top Buyers

HolderShares% AssetsChange
Cooperman leon g3.45M0.68%1.43M
Blackrock funding, inc. /de2.25M0.00%396.10K
Squarepoint ops145.25K0.00%145.25K
Ci private wealth140.00K0.00%140.00K
Geode capital management894.12K0.00%113.60K

Top Sellers

HolderShares% AssetsChange
First manhattan co. llc.---455.00K
Sei investments---111.32K
Aristides capital---106.33K
Wellington management group llp---103.70K
Eam investors---91.42K

New Positions

HolderShares% AssetsChangeValue
Squarepoint ops145.25K0.00%145.25K$1.02M
Ci private wealth140.00K0.00%140.00K$961.80K
Cantor fitzgerald, l. p.100.00K0.01%100.00K$687.00K
Sixth street partners management company96.69K0.00%96.69K$680.71K
Cobalt capital management90.00K0.45%90.00K$633.60K

Sold Out

HolderChange
Rothschild investment-3.00
Mai capital management-9.00
Yankcom partnership-200.00
Federation des caisses desjardins du quebec-230.00
Tortoise investment management-500.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202690-11.76%12,569,2517.44%234.94%45-8.16%19-20.83%
Mar 31, 202679-16.84%8,920,167-26.00%183.22%37-32.73%18-10.00%
Dec 31, 202522-72.50%1,075,644-91.57%20.25%11-80.00%5-54.55%
Sep 30, 202519-65.45%1,067,231-87.45%20.63%10-73.68%4-
Jun 30, 202557-5.00%8,620,53214.72%206.52%3911.43%5-50.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF747.20K1.74%-
iShares Russell 2000 ETF913.04K1.69%-16.22K
Vanguard Total Stock Mkt Idx Inv839.16K1.63%-18.51K
Vanguard Institutional Extnd Mkt Idx Tr360.56K0.67%5.03K
Fidelity Small Cap Index341.17K0.63%1.35K
iShares Russell 2000 Growth ETF335.78K0.62%-3.07K
Russell 2000 Equity Index Fund B272.08K0.50%64.81K
Russell 2000 Index Non-Lendable Fund272.08K0.50%64.81K
Vanguard Russell 2000 ETF205.67K0.38%-4.70K
State St Russell Sm/Mid Cp® Indx SL Cl I204.30K0.38%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 21, 2025STAHLBERG JAN-Buy$1.55M
Nov 20, 2025STAHLBERG JAN-Buy$951.21K
Nov 25, 2025STAHLBERG JAN-Buy$626.82K
Nov 24, 2025STAHLBERG JAN-Buy$317.72K
Nov 19, 2025STAHLBERG JAN-Buy$1.73M

Insider Transactions Trends


DateBuySell
2026 Q3--
2026 Q1--
2025 Q47-
2025 Q312-
2025 Q2--

DMAC Ownership FAQ


Who Owns DiaMedica Therapeutics?

DiaMedica Therapeutics shareholders are primarily institutional investors at 23.37%, followed by 27.83% insiders and 48.80% retail investors. The average institutional ownership in DiaMedica Therapeutics's industry, Biotech Stocks , is 379.61%, which DiaMedica Therapeutics falls below.

Who owns the most shares of DiaMedica Therapeutics?

DiaMedica Therapeutics’s largest shareholders are Cooperman leon g (3.45M shares, 6.41%), Blackrock funding, inc. /de (2.25M shares, 4.19%), and Paragon associates & paragon associates ii joint venture (875K shares, 1.86%). Together, they hold 12.46% of DiaMedica Therapeutics’s total shares outstanding.

Does Blackrock own DiaMedica Therapeutics?

BlackRock is not among the top 10 institutional shareholders of DiaMedica Therapeutics.

Who is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested?

Paragon associates & paragon associates ii joint venture is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.05% of its assets in 875K DiaMedica Therapeutics shares, valued at 5.92M$.

Who is the top mutual fund holder of DiaMedica Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of DiaMedica Therapeutics shares, with 1.74% of its total shares outstanding invested in 747.2K DiaMedica Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools